Disposable Lancets Market Scope
The market for disposable lancets is rapidly increasing around the world. A significant number of people afflicted by serious medical conditions or diseases such as dyslipidemia, diabetes, and hyperlipidemia are expected to boost global demand for disposable lancets. Using a disposable lancet is a painless and easy operation. It can be used to check fat levels, blood sugar levels, and hemoglobin levels. It's also used to check for vital blood components. To reduce the risk of diseases caused by blood transfusions, healthcare facilities use disposable lancets. There has also been an increase in R&D for the production of single-use, cost-effective, and multipurpose lancets.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United Kingdom Players will contribute to the maximum growth of Europe Disposable Lancets market throughout the predicted period.
Roche Holding AG (Switzerland), LifeScan, Inc. (United States), Becton Dickinson (United States), Bayer AG (Germany), Abbott Laboratories (United States), B. Braun Melsungen (Germany), ARKRAY Healthcare Pvt. Ltd. (India), Terumo Corporation (Japan), I Sens Inc (South Korea) and SANNUO (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Yicheng (China) and Yuwell (China).
Segmentation Overview
The study have segmented the market of Europe Disposable Lancets market by Type (Safety Disposable Lancet, Homecare Disposable Lancet and Others), by Application (Cholesterol Tests, Glucose Tests and Others) and Region with country level break-up.
On the basis of geography, the market of Disposable Lancets has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Trend:
Growing Demand in Clinics, Hospitals, and Homecare Settings
Market Growth Drivers:
Increasing Use in Blood Glucose Monitoring Applications and Several other Diagnostic Tests that Involve Drawing of Blood and Rising Demand for Fast, Safe and Better Diabetes Care Products
Challenges:
Lack of Awareness among People in the Underdeveloped Countries
Restraints:
Poor Reimbursement Scenario especially in the Developing Countries
Opportunities:
Technological Advancement in Manufacturing Portable and Painless Lancets and High Growth Prospects in Emerging Countries
In August, 2023 - Roche Diabetes Care Japan Co., Ltd. announced the launch of Accu-Chek Pico, a handy and fully disposable lancet device for blood glucose monitoring to enhance diabetes care for older people living with diabetes nationwide
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Disposable Lancets Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.